(Q43146562)

14 November 2017

Endogenous and pharmacologic targeting of the STING pathway in cancer immunotherapy (English)

1 reference

14 November 2017

1 reference

1 reference

2

Thomas F Gajewski

1 reference

14 November 2017

Leticia Corrales

1

1 reference

14 November 2017

24 August 2015

1 reference

14 November 2017

1 reference

14 November 2017

77

1 reference

14 November 2017

245-247

1 reference

Direct Activation of STING in the Tumor Microenvironment Leads to Potent and Systemic Tumor Regression and Immunity

14 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4666728

Immune checkpoint blockade: a common denominator approach to cancer therapy

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4666728

STING-Dependent Cytosolic DNA Sensing Promotes Radiation-Induced Type I Interferon-Dependent Antitumor Immunity in Immunogenic Tumors.

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4666728

STING-dependent cytosolic DNA sensing mediates innate immune recognition of immunogenic tumors.

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4666728

Cancer immunotherapy strategies based on overcoming barriers within the tumor microenvironment

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4666728

Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4666728

Type I interferon is selectively required by dendritic cells for immune rejection of tumors

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4666728

Host type I IFN signals are required for antitumor CD8+ T cell responses through CD8{alpha}+ dendritic cells

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4666728

The efficacy of radiotherapy relies upon induction of type i interferon-dependent innate and adaptive immunity

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4666728

Chemokine expression in melanoma metastases associated with CD8+ T-cell recruitment

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4666728

10.1016/J.CYTO.2015.08.258

25 May 2018

Identifiers

DOI

1 reference

14 November 2017

1 reference

PMC publication ID

4666728

14 November 2017

PubMed publication ID

26315534

1 reference

PMC publication ID

4666728